Alembic Pharmaceuticals planning to raise Rs 150 crore via NCDs

13 Mar 2019 Evaluate

Alembic Pharmaceuticals is planning to raise fund by issue and allotment of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of up to Rs 150 crore on Private Placement Basis under Tranche III. The company’s NCD committee will consider the same in the meeting to be held on March 19, 2019.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

852.30 -4.95 (-0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×